Carr Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
4,206
+28
| +0.7% | +$3.1K | 0.14% | 100 |
|
|
2025
Q1 | $468K | Sell |
4,178
-1,472
| -26% | -$165K | 0.15% | 94 |
|
|
2024
Q4 | $522K | Sell |
5,650
-1,939
| -26% | -$179K | 0.16% | 92 |
|
|
2024
Q3 | $636K | Buy |
7,589
+65
| +0.9% | +$5.45K | 0.19% | 89 |
|
|
2024
Q2 | $516K | Buy |
7,524
+80
| +1% | +$5.49K | 0.16% | 103 |
|
|
2024
Q1 | $545K | Sell |
7,444
-195
| -3% | -$14.3K | 0.18% | 98 |
|
|
2023
Q4 | $619K | Buy |
7,639
+1
| +0% | +$81 | 0.23% | 73 |
|
|
2023
Q3 | $623K | Hold |
7,638
| – | – | 0.25% | 70 |
|
|
2023
Q2 | $589K | Buy |
7,638
+73
| +1% | +$5.63K | 0.24% | 76 |
|
|
2023
Q1 | $628K | Sell |
7,565
-940
| -11% | -$78K | 0.28% | 74 |
|
|
2022
Q4 | $730K | Buy |
+8,505
| New | +$730K | 0.38% | 61 |
|